Gelion secures three new US battery tech patents
By Josh White
Date: Wednesday 26 Feb 2025
(Sharecast News) - Gelion announced on Wednesday that it has secured three new patents in the United States for its core lithium-sulfur (LiS) battery technology, further strengthening its intellectual property portfolio.
The AIM-traded firm said the patents cover key advancements, including improvements in cycling performance, cathode structural integrity, and a one-step manufacturing process for single- or double-sided electrodes.
It said the developments aligned with its strategic roadmap, and reinforced its position in the LiS battery sector.
The company said it now held more than 200 patents and patent applications across 44 families, covering various aspects of battery technology, from anodes and cathodes to electrolytes, manufacturing processes, and battery management systems.
It said the latest patents would contribute to its broader strategy of securing comprehensive intellectual property protection across the entire LiS battery value chain.
In addition, Gelion said it had received acceptance from the US Patent and Trademark Office for a recycling patent application focused on improving the recovery of high-value metals such as nickel and cobalt from waste batteries.
The patent outlined a method for removing iron impurities, enhancing metal purity in the recycling process.
Gelion said it expected the progress in the US to support applications in other key markets, including Europe and China.
The company is currently developing its recycling technology with funding support from the UK government, and is exploring commercialisation opportunities including securing independent funding.
It said its recycling IP portfolio now comprised nine patent families, with patents granted or under examination.
"Gelion's scientists and engineers are diligently advancing our leadership in sulfur battery technology as we unlock its full potential," said chief executive officer John Wood.
"Securing the confidence of our supply chain partners is essential as commercialisation progresses, particularly regarding IP rights.
"To achieve this, we leverage both our internal expertise and world-class advisors."
Wood said patent grants served as a "testament" to the company's innovation, adding that it actively develops, reviews and refines - including consolidation of areas where it assessed value did not merit cost - its portfolio to maximise and concentrate value.
"Our focus remains on building a high-quality IP portfolio that strengthens our commercial objectives."
At 1020 GMT, shares in Gelion were up 2.35% at 13.05p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN